Filing Details

Accession Number:
0001209191-20-036045
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-11 18:29:09
Reporting Period:
2020-06-11
Accepted Time:
2020-06-11 18:29:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645666 Kezar Life Sciences Inc. KZR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1273885 M Franklin Berger C/o Kezar Life Sciences, Inc.
4000 Shoreline Court, Suite 300
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-11 100,000 $5.50 784,003 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Shares were purchased in a public offering of the Issuer at a public offering price of $5.50.